Bank Of New York Mellon Corp Kura Oncology, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $2.59 Million - $3.9 Million	230,665 New	230,665 $2.86 Million
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $262,070 - $424,418	21,821 Added 10.55%	228,661 $3.12 Million
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $265,747 - $454,822	-24,813 Reduced 10.71%	206,840 $3.79 Million
Q1 2022 May 11, 2022	BUY	$11.78 - $16.98 $9,565 - $13,787	812 Added 0.35%	231,653 $3.72 Million
Q4 2021 Feb 11, 2022	SELL	$12.22 - $19.57 $296,090 - $474,181	-24,230 Reduced 9.5%	230,841 $3.23 Million
Q3 2021 Nov 12, 2021	BUY	$15.42 - $21.72 $560,532 - $789,543	36,351 Added 16.62%	255,071 $4.78 Million
Q2 2021 Aug 11, 2021	SELL	$20.85 - $29.88 $1.66 Million - $2.38 Million	-79,622 Reduced 26.69%	218,720 $4.56 Million
Q1 2021 May 13, 2021	BUY	$24.75 - $39.14 $315,463 - $498,878	12,746 Added 4.46%	298,342 $8.43 Million
Q4 2020 Feb 09, 2021	BUY	$29.0 - $41.62 $1.25 Million - $1.79 Million	43,007 Added 17.73%	285,596 $9.33 Million
Q3 2020 Nov 12, 2020	BUY	$16.3 - $30.64 $581,844 - $1.09 Million	35,696 Added 17.25%	242,589 $7.43 Million
Q2 2020 Aug 12, 2020	BUY	$7.95 - $18.81 $453,666 - $1.07 Million	57,065 Added 38.09%	206,893 $3.37 Million
Q1 2020 May 06, 2020	BUY	$6.45 - $14.04 $31,727 - $69,062	4,919 Added 3.39%	149,828 $1.49 Million
Q4 2019 Feb 14, 2020	BUY	$12.97 - $15.94 $49,558 - $60,906	3,821 Added 2.71%	144,909 $1.99 Million
Q3 2019 Nov 07, 2019	BUY	$14.75 - $20.87 $286,681 - $405,629	19,436 Added 15.98%	141,088 $2.14 Million
Q2 2019 Aug 12, 2019	SELL	$14.71 - $19.79 $6,089 - $8,193	-414 Reduced 0.34%	121,652 $2.4 Million
Q1 2019 May 14, 2019	BUY	$13.73 - $16.87 $8,141 - $10,003	593 Added 0.49%	122,066 $2.03 Million
Q4 2018 Feb 11, 2019	BUY	$10.6 - $17.49 $97,710 - $161,222	9,218 Added 8.21%	121,473 $1.71 Million
Q3 2018 Nov 09, 2018	BUY	$16.65 - $21.85 $164,568 - $215,965	9,884 Added 9.66%	112,255 $0
Q2 2018 Aug 06, 2018	BUY	$14.8 - $18.8 $282,265 - $358,553	19,072 Added 22.9%	102,371 $1.86 Million
Q1 2018 May 15, 2018	BUY	$14.5 - $23.4 $237,263 - $382,894	16,363 Added 24.45%	83,299 $1.56 Million
Q4 2017 Feb 09, 2018	BUY	$13.5 - $16.65 $903,636 - $1.11 Million	66,936	66,936 $1.02 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

Suvretta Capital Management, LLC New York, NY

7.65M
Shares

$69 Million
5.88% of portfolio
Black Rock Inc. New York, NY

6.97M
Shares

$62.8 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.81M
Shares

$52.3 Million
4.92% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

5.41M
Shares

$48.8 Million
1.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.33M
Shares

$39 Million
3.05% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account